Provided by Tiger Trade Technology Pte. Ltd.

ODDITY Tech Ltd.

44.30
-0.4700-1.05%
Volume:101.01K
Turnover:4.50M
Market Cap:2.54B
PE:24.72
High:44.89
Open:44.52
Low:44.00
Close:44.77
52wk High:79.18
52wk Low:35.30
Shares:57.44M
Float Shares:38.70M
Volume Ratio:0.73
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.79
EPS(LYR):1.77
ROE:29.74%
ROA:9.38%
PB:6.68
PE(LYR):25.03

Loading ...

Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

GlobeNewswire
·
2 hours ago

Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026

GlobeNewswire
·
2 hours ago

Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile

GlobeNewswire
·
Dec 09

Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
Dec 08

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

GlobeNewswire
·
Dec 08

Cboe to Offer Nearly 24-Hour Trading for Russell 2000 Options, Expanding Global Access to U.S. Small-Cap Equities

prnewswire
·
Dec 03

Unicycive Therapeutics to Participate in Upcoming Investor Events in December

GlobeNewswire
·
Nov 25

Oddity Tech's Methodiq Telehealth Platform to be Key Driver for Stock Going Ahead, Morgan Stanley Says

MT Newswires Live
·
Nov 21

Stock Track | ODDITY Tech Plummets 5.21% as Multiple Analysts Slash Price Targets

Stock Track
·
Nov 21

Stock Track | ODDITY Tech Plummets 5.21% as Multiple Analysts Slash Price Targets

Stock Track
·
Nov 21

ODDITY Tech Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Nov 21

Morgan Stanley Lowers Price Target on ODDITY Tech to $49 From $61, Keeps Equalweight Rating

MT Newswires Live
·
Nov 21

Bath & Body Works, Inc. : Morgan Stanley Cuts to Equal-Weight From Overweight

THOMSON REUTERS
·
Nov 21

Bath & Body Works, Inc. : Morgan Stanley Cuts Target Price to $18.00 From $43.00

THOMSON REUTERS
·
Nov 21

Oddity Tech Ltd : Morgan Stanley Cuts Target Price to $49.00 From $61.00

THOMSON REUTERS
·
Nov 21

ODDITY Tech Price Target Maintained With a $72.00/Share by Needham

Dow Jones
·
Nov 21

Oddity price target lowered to $46 from $64 at Barclays

TIPRANKS
·
Nov 21

Post-Bell | US Stocks Slump With Nasdaq Down 2%; Tesla Falls 2%; Nvidia Drops 3%; Micron Sinks 11%; SanDisk Tumbles 20%

Tiger Newspress
·
Nov 21

BUZZ-U.S. STOCKS ON THE MOVE-Apollo Global, Exact Sciences, Eaton

Reuters
·
Nov 21

Oddity price target lowered to $70 from $80 at KeyBanc

TIPRANKS
·
Nov 21